cerliponase alfa
cerliponase alfa is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Brineura. Available dosage forms: injection, solution, kit.
Drug Details
- Generic Name
- cerliponase alfa
- Brand Names
- Brineura
- Application Number
- BLA761052
- Sponsor
- BioMarin Pharmaceutical Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION, KIT
- Routes
- N/A
- Active Ingredients
- CERLIPONASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE BRINEURA is indicated to slow the loss of ambulation in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency. BRINEURA is a hydrolytic lysosomal N-terminal tripeptidyl peptidase indicated to slow the loss of ambulation in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency. ( 1 )